@article{aad9af25432546d78fc3a3743345996b,
title = "Thrombocytopenia in Children and Young Adults Undergoing Continuous Renal Replacement Therapy: A WE-ROCK Study",
abstract = "Introduction: Thrombocytopenia in patients treated with continuous renal replacement therapy (CRRT) in adults is associated with mortality. Pediatric data are limited. The association between pre-CRRT thrombocytopenia and platelet decline at 24 h of CRRT with outcomes was evaluated. Methods: Secondary analysis of the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) includes patients' birth-25 years who underwent CRRT. Exclusions were end-stage kidney disease, non-acute kidney injury/fluid overload CRRT indication, concurrent extracorporeal membrane oxygenation, missing baseline platelets, platelet disorders, and hematologic malignancy. Primary exposures were (i) pre-CRRT thrombocytopenia (≤100 × 103/μL) and (ii) ≥30\% decline at 24 h of CRRT in those with pre-CRRT >100 × 103/μL. Primary outcome was survival to intensive care unit (ICU) discharge. Secondary outcomes included major adverse kidney events at 90 days (MAKE-90) (death, dialysis dependence, creatinine >125\% baseline) from CRRT initiation. Results: A total of 805 patients were included. Overall, 63.9\% had baseline thrombocytopenia, median (IQR) platelets of 38 (20, 63) ×103/μL. Baseline thrombocytopenia occurred in younger septic patients with higher illness severity. A ≥30\% decline occurred in 33\% of patients. Those with a ≥30\% platelet decline were more commonly younger patients and had smaller catheters. Pre-CRRT thrombocytopenia and platelet decline were associated with ICU mortality in univariate but not multivariate models. There was no association with MAKE- 90. Conclusions: Thrombocytopenia is common prior to CRRT initiation and is associated with greater illness severity. These findings stress the importance of vigilant monitoring of platelet levels before CRRT initiation and during therapy as thrombocytopenia at both time points may be a prognostic indicator. Additionally, this study highlights the need for future research to clarify the interplay of patient and mechanical factors in this phenomenon and guide potential interventions.",
keywords = "Acute kidney injury, Continuous renal replacement therapy, Critically ill children, MAKE-90, Thrombocytopenia",
author = "\{behalf of WE-ROCK Investigators\} and Abby Basalely and Gist, \{Katja M.\} and Stanski, \{Natalja L.\} and Fuhrman, \{Dana Y.\} and Seo, \{Jang Dong\} and Ollberding, \{Nicholas J.\} and Amy Strong and Mihaela Damian and Catherine Morgan and Stephanie Reynaud and Melissa Muff-Luett and Akash Deep and Carmela Serpe and Krallman, \{Kelli A.\} and Shina Menon and Emily Ahern and Arikan, \{Ayse Akcan\} and Issa Alhamoud and Rashid Alobaidi and Pilar Anton-Martin and Balani, \{Shanthi S.\} and Matthew Barhight and Bigelow, \{Amee M.\} and Gabriella Bottari and Andrea Cappoli and Ciccia, \{Eileen A.\} and Michaela Collins and Denise Colosimo and Gerard Cortina and Damian, \{Mihaela A.\} and \{De la Mata Navazo\}, Sara and Gabrielle Deabreu and Ding, \{Kathy L.\} and Dolan, \{Kristin J.\} and Lafever, \{Sarah NFernandez\} and Fuhrman, \{Dana Y.\} and Ben Gelbart and Gorga, \{Stephen M.\} and Francesco Guzzi and Isabella Guzzo and Taiki Haga and Elizabeth Harvey and Hasson, \{Denise C.\} and Taylor Hill-Horowitz and Haleigh Inthavong and Catherine Joseph and Ahmad Kaddourah and Aadil Kakajiwala and Kessel, \{Aaron D.\} and Sarah Korn and Krallman, \{Kelli A.\} and Kwiatkowski, \{David M.\} and Jasmine Lee and Laurance Lequier and Kia, \{Tina Madani\} and Mah, \{Kenneth E.\} and Eleonora Marinari and Martin, \{Susan D.\} and Mohamed, \{Tahagod H.\} and Mottes, \{Theresa A.\} and Muff-Luett, \{Melissa A.\} and Siva Namachivayam and Neumayr, \{Tara M.\} and Abigail O'rourke and Ollberding, \{Nicholas J.\} and Pinto, \{Matthew G.\} and Dua Qutob and Valeria Raggi and Zaccaria Ricci and Rumlow, \{Zachary A.\} and Lozano, \{Mar{\'i}a J.Santiago\} and Emily See and Selewski, \{David T.\} and Alyssa Serratore and Ananya Shah and Shih, \{Weiwen V.\} and Hstella Shin and Slagle, \{Cara L.\} and Sonia Solomon and Soranno, \{Danielle E.\} and Rachana Srivastava and Stanski, \{Natalja L.\} and Starr, \{Michelle C.\} and Stenson, \{Erin K.\} and Strong, \{Amy E.\} and Taylor, \{Susan A.\} and Thadani, \{Sameer V.\} and Uber, \{Amanda M.\} and Webb, \{Tennille N.\} and Huaiyu Zang and Zangla, \{Emily E.\} and Michael Zappitelli and T. Christine and E. Alvarez and Elizabeth Bixler and Brown, \{Erica Blender\} and Brown, \{Cheryl L.\} and Ambra Burrell and Anwesh Dash and Ehrlich, \{Jennifer L.\} and Simrandeep Farma and Kim Gahring and Barbara Gales and Hilgenkamp, \{Madison R.\} and Sonal Jain and Kate Kanwar and Jennifer Lusk and Meyer, \{Christopher J.\} and Katherine Plomaritas and Joshua Porter and Jessica Potts and Nurs, \{Alyssa Serratore B.\} and Elizabeth Schneider and Vidushi Sinha and Strack, \{P. J.\} and Sue Taylor and Katherine Twombley and \{Van Wyk\}, Brynna and Samantha Wallace and Janet Wang and Megan Woods and Marcia Zinger and Alison Zong",
note = "Publisher Copyright: {\textcopyright} 2025 The Author(s).",
year = "2025",
month = jul,
day = "1",
doi = "10.1159/000545777",
language = "English",
volume = "54",
pages = "322--333",
journal = "Blood Purification",
issn = "0253-5068",
number = "6",
}